Investigational Site Number 840674 — New Windsor, New York

Investigational Site Number 840674 is a clinical research site located in New Windsor, New York, United States 12553.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840674 has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840674?

Investigational Site Number 840674 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840674 conducted?

Investigational Site Number 840674 has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Investigational Site Number 840674 accredited by Crixeo Health?

Investigational Site Number 840674 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840674?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.